Biotech Boom: Stocks Skyrocketing & What's Next Hosted by Laycee KluinMarch 5, 2024 ShareLink copied to clipboard. Play video for Biotech Boom: Stocks Skyrocketing & What's NextDetailsGuestsFrom the surging trend in weight loss megatrends to the innovative strides in smart chemotherapy, Dylan Jovine from Behind The Markets breaks down the shifts he's observed. We delve into the burgeoning weight loss market led by giants like Eli Lilly and Novo Nordisk, and the strategic acquisitions by big pharma to incorporate breakthrough weight loss drugs into their portfolios. Dylan also shares his golden rules for evaluating biotech stocks, emphasizing the importance of late-stage companies, strategic partnerships, and experienced management. Furthermore, we explore the emerging areas within biotech, notably the revolutionary smart chemo, and discuss the financial health and future prospects of biotech companies. Despite the risks and challenges facing the industry, including a shortfall in private funding, Dylan's insights provide valuable guidance for investors navigating this rapidly evolving sector.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioLLYEli Lilly and Company4.9092 of 5 stars$1,005.20-0.1%0.69%35.55NVONovo Nordisk A/S4.6312 of 5 stars$44.71-2.4%3.91%10.49IMGNImmunoGenN/A$31.23N/AN/AGSKGSK3.3946 of 5 stars$49.66-2.5%3.79%12.90BMYBristol Myers Squibb4.8057 of 5 stars$57.04+0.5%4.42%16.02IOVAIovance Biotherapeutics2.6323 of 5 stars$3.46-1.8%N/AN/A Compare These Stocks Add These Stocks to My Watchlist Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube Listen to MarketBeat Other Platforms Market Braces for Mag 7 Earnings ImpactMarketBeat TV | April 27, 2026Watch VideoRecent VideosIs This Palantir's Last Great Wealth Opportunity?MarketBeat TV | May 14, 2026Watch VideoThe Last Big Wealth Opportunity Before China Cuts Us Off (3 Stocks to Buy Now)MarketBeat TV | May 13, 2026Watch VideoIf You Own Stocks, Get READY for May 15thMarketBeat TV | May 12, 2026Watch Video Featured Articles and OffersBeyond NVIDIA: Picks-and-Shovels AI Plays with Strong MomentumMay 10, 2026Your book is insideFrom Profits Run (Ad)Before the Moon Base Gets Built, These 4 Companies WinMay 11, 2026Meta Platforms’ Wild Post-Earnings Swings: Where Analyst Price Targets Stand NowMay 11, 2026The DRAM Shake-Up: Samsung Stumbles, Micron Chases $1000May 12, 2026"Golden Dawn": the code name that should be on every investor's radarFrom InvestorPlace (Ad) Search Headlines Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Hosted by Laycee KluinMarch 5, 2024 ShareLink copied to clipboard. Play video for Biotech Boom: Stocks Skyrocketing & What's NextDetailsGuestsFrom the surging trend in weight loss megatrends to the innovative strides in smart chemotherapy, Dylan Jovine from Behind The Markets breaks down the shifts he's observed. We delve into the burgeoning weight loss market led by giants like Eli Lilly and Novo Nordisk, and the strategic acquisitions by big pharma to incorporate breakthrough weight loss drugs into their portfolios. Dylan also shares his golden rules for evaluating biotech stocks, emphasizing the importance of late-stage companies, strategic partnerships, and experienced management. Furthermore, we explore the emerging areas within biotech, notably the revolutionary smart chemo, and discuss the financial health and future prospects of biotech companies. Despite the risks and challenges facing the industry, including a shortfall in private funding, Dylan's insights provide valuable guidance for investors navigating this rapidly evolving sector.Stocks Mentioned in This EpisodeCompanyMarketRank™Current PriceDividend YieldP/E RatioLLYEli Lilly and Company4.9092 of 5 stars$1,005.20-0.1%0.69%35.55NVONovo Nordisk A/S4.6312 of 5 stars$44.71-2.4%3.91%10.49IMGNImmunoGenN/A$31.23N/AN/AGSKGSK3.3946 of 5 stars$49.66-2.5%3.79%12.90BMYBristol Myers Squibb4.8057 of 5 stars$57.04+0.5%4.42%16.02IOVAIovance Biotherapeutics2.6323 of 5 stars$3.46-1.8%N/AN/A Compare These Stocks Add These Stocks to My Watchlist Laycee Kluin, HostDigital Marketing Strategist, MarketBeatAs MarketBeat's Digital Marketing Strategist, Laycee helps with the marketing side of tasks including developing email campaigns, running the promotion of the MarketBeat products and exploring social media opportunities. She felt called to the Marketing industry because she enjoys collaborating with people and making connections. The University of Sioux Falls alum majored in Media Studies with minors in Communications and Spanish. Laycee brings a background in Financial Services Marketing.Previous VideoAll VideosNext Video Subscribe on YouTube Don't Miss a Video Subscribe to watch the latest stock market videos from MarketBeat. We empower investors to make better trading decisions by providing real-time financial data and objective market analysis. Subscribe on YouTube
